secwatch / observer
8-K filed July 17, 2023, 7:59 PM ET ticker ELTP CIK 0001053369
other confidence high sentiment neutral materiality 0.35

ELITE PHARMACEUTICALS INC /NV/ (ELTP): auditor change — Elite Pharmaceuticals dismisses Buchbinder, appoints Mazers as new auditor

ELITE PHARMACEUTICALS INC /NV/

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

ELITE PHARMACEUTICALS INC /NV/ engaged Mazers USA LLP as its auditor.

Action
engagement
Auditor
Mazers USA LLP
Exact text from the filing
Company”) approved the appointment, effective July 11, 2023, of Mazers USA LLP (“Mazers”) as the Company’s new independent registered public accounting firm to audit the Company’s consolidated financial statements for the year ending
View on SEC.gov
Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

ELITE PHARMACEUTICALS INC /NV/ dismissed Buchbinder Tunick & Company LLP as its auditor.

Action
dismissal
Auditor
Buchbinder Tunick & Company LLP
Successor
Mazers USA LLP
Exact text from the filing
The Audit Committee also dismissed Buchbinder Tunick & Company LLP (“Buchbinder”) as the Company’s independent registered public accounting firm, effective as of July 12, 2023.
View on SEC.gov

56 auditor changes filed in the last 30 days. Browse all auditor changes →

ELITE PHARMACEUTICALS INC /NV/ filing history →

Source: SEC EDGAR
accession 0001493152-23-024726
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.